Insights into Network of Hot Spots of Aggregation in Nucleophosmin 1.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Nov 2022
Historique:
received: 31 10 2022
revised: 16 11 2022
accepted: 21 11 2022
entrez: 11 12 2022
pubmed: 12 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

In a protein, point mutations associated with diseases can alter the native structure and provide loss or alteration of functional levels, and an internal structural network defines the connectivity among domains, as well as aggregate/soluble states' equilibria. Nucleophosmin (NPM)1 is an abundant nucleolar protein, which becomes mutated in acute myeloid leukemia (AML) patients. NPM1-dependent leukemogenesis, which leads to its aggregation in the cytoplasm (NPMc+), is still obscure, but the investigations have outlined a direct link between AML mutations and amyloid aggregation. Protein aggregation can be due to the cooperation among several hot spots located within the aggregation-prone regions (APR), often predictable with bioinformatic tools. In the present study, we investigated potential APRs in the entire NPM1 not yet investigated. On the basis of bioinformatic predictions and experimental structures, we designed several protein fragments and analyzed them through typical aggrsegation experiments, such as Thioflavin T (ThT), fluorescence and scanning electron microscopy (SEM) experiments, carried out at different times; in addition, their biocompatibility in SHSY5 cells was also evaluated. The presented data clearly demonstrate the existence of hot spots of aggregation located in different regions, mostly in the N-terminal domain (NTD) of the entire NPM1 protein, and provide a more comprehensive view of the molecular details potentially at the basis of NPMc+-dependent AML.

Identifiants

pubmed: 36499032
pii: ijms232314704
doi: 10.3390/ijms232314704
pmc: PMC9736328
pii:
doi:

Substances chimiques

Amyloid 0
Amyloidogenic Proteins 0
Nuclear Proteins 0
Nucleophosmin 117896-08-9
NPM1 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

Cell. 2015 Nov 5;163(4):829-39
pubmed: 26544936
Biochim Biophys Acta Gen Subj. 2018 Apr;1862(4):967-978
pubmed: 29330024
Proteins. 2007 Nov 15;69(3):672-8
pubmed: 17879352
PLoS Biol. 2006 Jan;4(1):e6
pubmed: 16300414
Cell Commun Signal. 2016 Jan 05;14:1
pubmed: 26727894
Bioorg Chem. 2022 Oct;127:106001
pubmed: 35803020
Anal Biochem. 2020 May 15;597:113691
pubmed: 32194074
EMBO Rep. 2016 Dec;17(12):1776-1784
pubmed: 27827794
Cell Rep. 2020 Apr 14;31(2):107512
pubmed: 32294448
Proc Natl Acad Sci U S A. 2011 Mar 8;108(10):4194-9
pubmed: 21325059
FEBS J. 2018 Mar;285(5):828-831
pubmed: 29527821
Oncotarget. 2016 Sep 13;7(37):59129-59143
pubmed: 27494862
Int J Pharm. 2010 May 10;390(2):89-99
pubmed: 20188160
FEBS J. 2019 Jun;286(12):2311-2328
pubmed: 30921500
Nature. 2017 Jul 13;547(7662):185-190
pubmed: 28678775
Biochemistry. 1989 Feb 7;28(3):1033-9
pubmed: 2713355
Biochim Biophys Acta. 2014 Jun;1840(6):2050-9
pubmed: 24576674
EMBO J. 2022 Dec 17;41(2):e108591
pubmed: 34842295
Curr Opin Struct Biol. 2022 Apr;73:102343
pubmed: 35240456
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
Proc Natl Acad Sci U S A. 2015 Jun 16;112(24):E3095-103
pubmed: 26038575
Int J Mol Sci. 2021 Mar 16;22(6):
pubmed: 33809522
J Biol Chem. 2016 Sep 23;291(39):20787-97
pubmed: 27510036
Proc Natl Acad Sci U S A. 2014 Mar 25;111(12):4466-71
pubmed: 24616519
Science. 2009 Jul 17;325(5938):328-32
pubmed: 19541956
FASEB J. 2015 Sep;29(9):3689-701
pubmed: 25977257
BMC Bioinformatics. 2009 Jan 30;10 Suppl 1:S45
pubmed: 19208147
Colloids Surf B Biointerfaces. 2021 Jan;197:111439
pubmed: 33137636
J Mol Biol. 2018 Aug 3;430(16):2508-2520
pubmed: 29704492
J Pharm Sci. 2009 Sep;98(9):2909-34
pubmed: 18823031
Biochim Biophys Acta Proteins Proteom. 2019 Jun;1867(6):637-644
pubmed: 30710643
Int J Mol Sci. 2019 Feb 14;20(4):
pubmed: 30769904
Int J Biol Macromol. 2021 Oct 1;188:207-214
pubmed: 34364939
Bioinformatics. 2007 Sep 1;23(17):2218-25
pubmed: 17599928
J Mol Biol. 2018 Oct 12;430(20):3735-3750
pubmed: 29890117
BMC Mol Biol. 2016 Aug 24;17(1):19
pubmed: 27553022
Proc Natl Acad Sci U S A. 2010 Feb 23;107(8):3487-92
pubmed: 20133726
Nature. 2001 Mar 8;410(6825):165-6
pubmed: 11242064
Science. 2002 Feb 1;295(5556):851-5
pubmed: 11823641
Cell. 2021 Sep 16;184(19):4857-4873
pubmed: 34534463
PLoS One. 2012;7(6):e39369
pubmed: 22761773
J Biomol NMR. 1995 Jul;6(1):1-10
pubmed: 22911575
Int J Biol Macromol. 2020 Dec 1;164:3501-3507
pubmed: 32890557
Nanomaterials (Basel). 2021 Nov 20;11(11):
pubmed: 34835893
Soft Matter. 2022 Nov 16;18(44):8418-8426
pubmed: 36300826
Biochem Res Int. 2011;2011:195209
pubmed: 21152184
Cell. 2012 May 11;149(4):753-67
pubmed: 22579281
Int J Biol Macromol. 2019 Feb 1;122:517-525
pubmed: 30389521
Biochim Biophys Acta Gen Subj. 2022 Aug;1866(8):130173
pubmed: 35597503
Bioorg Chem. 2021 Aug;113:104997
pubmed: 34044346
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
J Biol Chem. 2008 Aug 22;283(34):23326-32
pubmed: 18511415
J Biochem. 2008 Apr;143(4):441-8
pubmed: 18024471
Phys Chem Chem Phys. 2016 Mar 21;18(11):8098-107
pubmed: 26923710
Biochem Biophys Res Commun. 1980 Jul 16;95(1):1-6
pubmed: 7417242
FEBS Lett. 2008 Apr 2;582(7):1073-80
pubmed: 18319061
Nat Cell Biol. 2002 Jul;4(7):529-33
pubmed: 12080348
Oncogenesis. 2017 Sep 18;6(9):e379
pubmed: 28920929
Nat Commun. 2018 Feb 26;9(1):842
pubmed: 29483575
Nat Methods. 2010 Mar;7(3):237-42
pubmed: 20154676
Biochem Biophys Res Commun. 2013 Jan 11;430(2):523-8
pubmed: 23232117
J Biol Chem. 2000 Aug 11;275(32):24451-7
pubmed: 10829026
Ann Neurol. 2011 Oct;70(4):532-40
pubmed: 22028219
Nature. 2018 Nov;563(7732):508-513
pubmed: 30464263
EMBO J. 2022 Aug 16;41(16):e110410
pubmed: 35698800
Elife. 2016 Feb 02;5:
pubmed: 26836305
Curr Biol. 2019 Oct 7;29(19):R930-R932
pubmed: 31593669

Auteurs

Daniele Florio (D)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.

Sara La Manna (S)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.

Concetta Di Natale (C)

Department of Chemical, Materials and Production Engineering, University of Naples "Federico II", 80125 Naples, Italy.

Marilisa Leone (M)

Institute of Biostructures and Bioimaging (CNR), 80145 Naples, Italy.

Flavia Anna Mercurio (FA)

Institute of Biostructures and Bioimaging (CNR), 80145 Naples, Italy.

Fabiana Napolitano (F)

Department of Translational Medical Science, University of Naples "Federico II", 80131 Naples, Italy.

Anna Maria Malfitano (AM)

Department of Translational Medical Science, University of Naples "Federico II", 80131 Naples, Italy.

Daniela Marasco (D)

Department of Pharmacy, University of Naples "Federico II", 80131 Naples, Italy.
Institute of Biostructures and Bioimaging (CNR), 80145 Naples, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH